DK1603564T3 - Anvendelse af pyridin-2-yl-methylaminderivater til fremstilling af et medikament til behandling af kroniske neuropatologiske eller psykogene smertesymptomer - Google Patents

Anvendelse af pyridin-2-yl-methylaminderivater til fremstilling af et medikament til behandling af kroniske neuropatologiske eller psykogene smertesymptomer

Info

Publication number
DK1603564T3
DK1603564T3 DK04720637T DK04720637T DK1603564T3 DK 1603564 T3 DK1603564 T3 DK 1603564T3 DK 04720637 T DK04720637 T DK 04720637T DK 04720637 T DK04720637 T DK 04720637T DK 1603564 T3 DK1603564 T3 DK 1603564T3
Authority
DK
Denmark
Prior art keywords
pyridin
treatment
analgesic
alkyl
methyl
Prior art date
Application number
DK04720637T
Other languages
Danish (da)
English (en)
Inventor
Francis Colpaert
Bernard Vacher
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK1603564T3 publication Critical patent/DK1603564T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
DK04720637T 2003-03-13 2004-03-15 Anvendelse af pyridin-2-yl-methylaminderivater til fremstilling af et medikament til behandling af kroniske neuropatologiske eller psykogene smertesymptomer DK1603564T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0303099A FR2852244B1 (fr) 2003-03-13 2003-03-13 Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene
PCT/FR2004/000630 WO2004083171A2 (fr) 2003-03-13 2004-03-15 Utilisation de derives de pyridin-2-yl-methylamine pour le traitement des symptomes de la douleur chronique neuropathique ou psychogene

Publications (1)

Publication Number Publication Date
DK1603564T3 true DK1603564T3 (da) 2007-10-01

Family

ID=32893267

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04720637T DK1603564T3 (da) 2003-03-13 2004-03-15 Anvendelse af pyridin-2-yl-methylaminderivater til fremstilling af et medikament til behandling af kroniske neuropatologiske eller psykogene smertesymptomer

Country Status (25)

Country Link
US (1) US8609694B2 (zh)
EP (1) EP1603564B1 (zh)
JP (1) JP4684994B2 (zh)
KR (1) KR101100002B1 (zh)
CN (1) CN1761467B (zh)
AT (1) ATE366111T1 (zh)
AU (1) AU2004222051B2 (zh)
BR (1) BRPI0408293A (zh)
CA (1) CA2518591C (zh)
CY (1) CY1106900T1 (zh)
DE (1) DE602004007364T2 (zh)
DK (1) DK1603564T3 (zh)
ES (1) ES2289494T3 (zh)
FR (1) FR2852244B1 (zh)
HK (1) HK1079120A1 (zh)
IL (1) IL170743A (zh)
MX (1) MXPA05009782A (zh)
NO (1) NO334997B1 (zh)
NZ (1) NZ542461A (zh)
PL (1) PL1603564T3 (zh)
PT (1) PT1603564E (zh)
RU (1) RU2359674C2 (zh)
UA (1) UA81023C2 (zh)
WO (1) WO2004083171A2 (zh)
ZA (1) ZA200507634B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071778B2 (en) 2006-07-27 2011-12-06 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
WO2009096941A1 (en) * 2008-01-28 2009-08-06 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in cns disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3925662B2 (ja) 1995-01-12 2007-06-06 グラクソ，グループ，リミテッド タキキニンアンタゴニスト活性を有するピペリジン誘導体
FR2755967B1 (fr) * 1996-11-21 1999-01-29 Pf Medicament Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
FR2784378B1 (fr) * 1998-10-09 2000-12-29 Pf Medicament Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments
FR2840900B1 (fr) * 2002-06-18 2005-02-25 Pf Medicament Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments

Also Published As

Publication number Publication date
EP1603564B1 (fr) 2007-07-04
RU2359674C2 (ru) 2009-06-27
AU2004222051B2 (en) 2009-01-15
JP4684994B2 (ja) 2011-05-18
WO2004083171A3 (fr) 2004-12-23
CA2518591A1 (fr) 2004-09-30
DE602004007364D1 (de) 2007-08-16
AU2004222051A1 (en) 2004-09-30
US20060241141A1 (en) 2006-10-26
UA81023C2 (en) 2007-11-26
WO2004083171A2 (fr) 2004-09-30
ZA200507634B (en) 2006-06-28
MXPA05009782A (es) 2005-12-05
ES2289494T3 (es) 2008-02-01
KR101100002B1 (ko) 2011-12-28
PL1603564T3 (pl) 2007-12-31
RU2005131615A (ru) 2006-02-10
US8609694B2 (en) 2013-12-17
NZ542461A (en) 2008-10-31
IL170743A (en) 2011-11-30
DE602004007364T2 (de) 2008-03-06
CA2518591C (fr) 2012-05-15
CN1761467A (zh) 2006-04-19
CN1761467B (zh) 2011-09-21
HK1079120A1 (en) 2006-03-31
NO334997B1 (no) 2014-08-18
CY1106900T1 (el) 2012-09-26
IL170743A0 (en) 2009-02-11
KR20050106120A (ko) 2005-11-08
PT1603564E (pt) 2007-09-24
FR2852244A1 (fr) 2004-09-17
FR2852244B1 (fr) 2007-09-07
JP2006520370A (ja) 2006-09-07
BRPI0408293A (pt) 2006-03-07
ATE366111T1 (de) 2007-07-15
EP1603564A2 (fr) 2005-12-14
NO20054673L (no) 2005-10-11

Similar Documents

Publication Publication Date Title
US9789117B2 (en) Use of sigma ligands in diabetes type-2 associated pain
CA2643802A1 (en) Methods for regulating neurotransmitter systems by inducing counteradaptations
MA28706B1 (fr) Antagoniste des recepteurs du glucagon, preparation et utilisations therapeutiques
CR9808A (es) Procedimiento de tratamiento de la arterosclerosis, dispilidemias y afecciones relacionadas y composiciones farmaceuticas
NO20064065L (no) Diaminopyrimidiner som P2X3 og P2X2/3 antagonister
ES2955490T3 (es) Métodos y composiciones para potenciar la acción de los analgésicos opioides mediante el uso de alcaloides de la iboga
ATE355103T1 (de) Coextrudierte sicherheits-dosierform mit einem wirkstoff und einem adversen mittel und herstellungsverfahren dafür
CN107417620A (zh) σ配体在阿片类药物诱导的痛觉过敏中的应用
US20080045610A1 (en) Methods for regulating neurotransmitter systems by inducing counteradaptations
WO2006049312A1 (ja) 神経因性疼痛治療剤
TW201536295A (zh) σ配體在與間質性膀胱炎／膀胱疼痛綜合徵（ＩＣ／ＢＰＳ）相關的疼痛的預防和治療中的應用
KR20110021823A (ko) 진통 내성 억제제
KR20060121178A (ko) 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제
Horita et al. Effects of TRH on the central nervous system of the rabbit
NO20054673L (no) Anvendelse av pyridin-2yl-metylaminderivater for fremstilling av et medikament beregnet for behandling av nevropatiske og psykogene kroniske smertesymptomer
US20070259945A1 (en) Method for treating pain
Lauretti Highlights in opioid agonists and antagonists
MX2022004610A (es) Uso de derivado de fenilquinolinona o derivado flavonoide para tratamiento del dolor neuropático.
ZA200702379B (en) Piperidine derivative or pharmaceutically acceptable salt thereof
Choudhury et al. The central nervous system depressant activities of Mycotoxin MT81 and its acetylated and benzoylated analogues
Kim The Effect of Intraarticular Morphine and Clonidine on Postoperative Analgesia after Knee Surgery.
Ashton et al. Neuropharmacological profile of R 18 503-induced wet-shake behavior in the rat: Noradrenergic and opiate components
WO2020106454A3 (en) Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
RU2334747C1 (ru) ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
TW202339719A (zh) 用於治療慢性腎臟病之醛固酮合成酶抑制劑